Editorial Board
The editorial board comprises of a panel of experts from various disciplines of medical and allied sciences to provide their expertise and guidance in maintaining the clarity of content and focus of the purpose of the journal.
Emeritus Editors

Dr. Purvish M. Parikh
MD, DNB, FICP, PHD, ECMO, CPI, MBA
Director of Precision Oncology Medical Oncologist & Hematologist
Asian Institute of Oncology,
Somaiya Hospital
Everard Nagar
off Eastern Express Highway
Sion East, Mumbai

Dr. Kumar Prabhash MD, DM
Professor
Medical Oncology
Tata Memorial Hospital
Parel, Mumbai, India
Editor-In-Chief

Dr. Randeep Singh MD/DM/ECMO/FCCP
Senior Consultant & Unit Head
( Artemis Hospitals, Gurgoan) Ex consultant Tata Memorial Hospital
Joint Secretary Indian Society Medical & Paediatric oncology (ISMPO)
Executive Member Indian cooperative oncology network (ICON)
Executive Member NCR Oncology Forum
Co-Founder Member International CME ORG
Delhi, India
Executive Editor

Dr. Radhika A. Vaishnav
Ph.D. (University of Kentucky, USA)
Director, Natureka Life Sciences Research Director
Vadodara Stroke Center Scientific Consultant
Harmony Clinic
Vadodara, Gujarat, India
Editors

Dr. Amit Verma MD (AIIMS)
Fellowship MD
Anderson Cancer Center (USA)
Principal Consultant Molecular Oncology and Cancer Genetics
Max Hospital, New Delhi

Dr. Ashish Gulia
Professor
Orthopaedic Oncology, Convener,
Bone and Soft Tissue Disease Management Group,
Tata Memorial Centre,
Mumbai, India
Joint Editors

Dr. (Sqn Ldr) HS Darling, MBBS, MD, DNB (Med Onc), ECMO, MRCP-UK (Med Onc)
Consultant, Medical Oncology & Hemato-Oncology
Command Hospital Air Force,
Bangalore-560007, India

Dr. Akhil Kapoor
Assistant Professor
DM Medical Oncology (TMH, Mumbai)
DNB Medical Oncology,
ESMO Certified Medical Oncologist,
Fellow ESMO,
Tata Memorial Hospital (HBCH & MPMMCC),
Varanasi, UP, India
Technical / Industry Advisory Board
Dr. Amit Choudhari PhD
VP research and Development
Medgenome, Foster city,
CA, USA
Dr. Darshana Patil MD
Medical Director
Datar Cancer Genetics Limited,
Maharashtra, India
Dr. Puneet Chandna PhD
Head
Ace Probe Technologies
Mumbai, Maharashtra, India
Dr. Shafi Gowhar PhD
VP computational Medicine and
translational research.
Dr. Swapnil Jaiswal MD
Disease area specialist
Bristol-Myers Squibb
Mumbai, Maharashtra, India
Dr. Manjeet Mehta PhD
Director
Genetic World
Mumbai, Maharashtra, India
Dr. Shalu Verma DVM, PhD
Vice President
R&D at CORE Diagnostics
Gurugram, Haryana, India
Dr. Sunita Polampalli MD
Senior Scientist
Global Gene Corp,
Mumbai, Maharashtra, India
Dr. Nikhil Phadke PhD
Founder Director
& Chief Scientific Officer,
GenePath Dx (Causeway Healthcare Pvt Ltd), India
Dr. Sooraj Ratnakumar PhD
Founder Scientist
Swagene,
Chennai, India
Mr. Satish Garimella
Founder & CEO at Olivo Inc
Durham, North Carolina
Dr. Kas Subramanian PhD
VP Bioinformatics
Syngene International
Bangalore, India
Dr. Narinder Singh PhD
Country Manager and KOl
Engagement Lead-India
Oxford Nanopore Technologies
Advisory Board
Dr. Anil Kumar Dhull
Senior Radiation & Clinical Oncologist
Post Graduate Institute of Medical Sciences
Rohtak, Haryana, 124001, INDIA
Dr. Prashant Mehta MD, DM (AIIMS)
Consultant and Unit Head
Consultant and Unit Head
Medical Oncology/Hematoncology/BMT
Asian Institute of Medical Sciences Faridabad
European Society for Medical Oncology certified
Managing Committee member
Indian Cooperative Oncology Network (ICON)
International Advisory Board
Dr. Preetha Rajaraman PhD
U.S. Health Attache
India & Regional Representative, South Asia.
Office of Global Affairs, DHHS, New Delhi, India
Dr. Prashant Jani MD
Founder Medical Director
OncoPath Diagnostics
Ontario, Canada.
Dr. Petros Giannikopoulos MD
Co-founder & President
Driver, San Francisco, California
Dr. Raju Kandimalla PhD
Research Associate
Baylor Scott and White Health
Dallas Texas, USA
Dr. Louisa Ludbrook PhD
Senior Director
Global Sales at Oxford Nanopore Technologies Ltd
UK
Dr. Tariq Mughal
Tufts University
School of Medicine USA.